Latest AI and machine learning research in dementia for healthcare professionals.
Alzheimer's disease (AD) is a complex neurodegenerative disorder characterized by widespread dysregulation of gene expression and regulatory pathways. MicroRNAs (miRNAs) act as key post-transcriptional regulators by modulating messenger RNAs (mRNAs), and their disruption can influence synaptic function, neuroinflammation, and neuronal survival. In this study, we present an integrative transcriptom...
High-dimensional structural MRI (sMRI) images are widely used for Alzheimer's Disease (AD) diagnosis. Most existing methods for sMRI representation learning rely on 3D architectures (e.g., 3D CNNs), slice-wise feature extraction with late aggregation, or apply training-free feature extractions using 2D foundation models (e.g., DINO). However, these three paradigms suffer from high computational co...
Background Distinguishing individuals with cognitive decline (CD), including early Alzheimers disease, from cognitively normal (CN) individuals is ess...
High-dimensional neuroimaging data presents challenges for assessing neurodegenerative diseases due to complex non-linear relationships. Variational A...
Synthetic neuroimaging data can mitigate critical limitations of real-world datasets, including the scarcity of rare phenotypes, domain shifts across ...
Background: Early diagnosis of dementia can significantly improve care planning and patient outcomes while delaying progression. Machine learning algo...
Objective Accurate and scalable disease phenotyping from electronic health records (EHRs) is foundational for predictive modeling and precision medici...
Discovery of sensitive and biologically grounded biomarkers is essential for early detection and monitoring of Alzheimer's disease (AD). Structural MR...
Early and accurate diagnosis of Alzheimer's Disease (AD) is critical for effective intervention. While previous studies have explored speech-based bio...
Early and accurate classification of Alzheimers disease (AD) from brain MRI scans is essential for timely clinical intervention and improved patient o...
Early detection of neurodegenerative diseases such as Alzheimer's Disease (AD) and Frontotemporal Dementia (FTD) is essential for reducing the risk of...
Estimating brain age (BA) from T1-weighted magnetic resonance images (MRIs) provides a useful approach to map the anatomic features of brain senescenc...
Parkinson's disease (PD) and Alzheimer's disease (AD) are the two most prevalent and incurable neurodegenerative diseases (NDs) worldwide, for which e...
Aging is often accompanied by cognitive decline, but the extent, timing, and severity of this process is subject to large inter-individual variability...
BackgroundThe ATN (Amyloid/Tau/Neurodegeneration) framework provides a theory-driven approach to Alzheimers disease (AD) classification using binary b...
The unknown pathogenic mechanisms of Alzheimer's disease (AD) make treatment challenging. Neuroimaging genetics offers a method for identifying diseas...
Objective While Alzheimer's disease (AD) and frontotemporal dementia (FTD) show some common memory deficits, these two disorders show partially over...
We introduce scenario-based cognitive status identification in older drivers from Naturalistic driving videos and large vision models. In recent tim...
Nerve conduction F-wave studies contain crucial information about subclinical motor dysfunction that can be used to diagnose patients with amyotrophic...
Alzheimer's disease (AD) is a neurodegenerative disorder that affects millions worldwide. In the absence of effective treatment options, early diagn...